NASDAQ$SIBN

SI-BONE Inc · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

SI-BONE reported Q3 2025, revenue of $35M, net loss of $6.5M.

For Q3 2025, SI-BONE reported revenue of $35M, a net loss of $6.5M. Management discusses operating trends, liquidity, and outlook in the quarterly filing.

  • Revenue $35M.
  • Net loss $6.5M.
  • SI-BONE highlights liquidity, operations, and near-term priorities.

Headline financials

Total Revenue

$48.7M

Previous: $40.3M+20.6%
EPS (adj)

-$0.11

Previous: -$0.16+31.3%
Gross margin

79.8%

No prior period
Adjusted EBITDA

$2.3M

No prior period
Active U.S. physicians

1.5K

No prior period
Capital Expenditures

-$7.13M

Previous: -$8.23M+13.4%
Net Income

-$4.57M

Previous: -$6.58M+30.6%
Operating Income

-$5.38M

Previous: -$7.63M+29.5%
Gross Profit

$38.8M

Previous: $31.9M+21.8%

Revenue & EPS history

SI-BONE · Revenue · Quarterly

$48.7M

Q3 2025+20.6%vs Q3 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

The filing outlines SI-BONE's outlook, including capital allocation, operating priorities, and sector risks relevant to upcoming periods.

Tailwinds

  • SI-BONE discusses operational execution and demand trends in the filing.
  • Balance sheet and liquidity actions support the business plan.

Headwinds

  • Macro, pricing, and cost inflation may pressure margins.
  • Segment mix and one-time items can affect comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-1.8%

Avg return

Earnings day

-1.3%

Avg return

5 days after

+0.0%

Avg return

30 days after

40%

12 / 30 earnings

Positive

+16.2%

Q4 2022

Best reaction

-23.7%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.3%+15.3%+25.1%
Q4 2025-1.0%-0.6%-17.8%
Q3 2025+16.1%+11.1%+20.0%
Q1 2025+15.6%+29.8%+33.8%
Q4 2024+5.6%+3.7%-19.9%
Q3 2024-17.5%-18.8%-14.5%
Q2 2024-3.6%-5.2%+10.2%
Q1 2024+10.4%+8.0%-1.1%
Q4 2023-12.4%-15.7%-22.0%
Q3 2023-4.7%-12.4%-0.9%
Q2 2023-12.5%-9.6%-7.1%
Q1 2023+9.6%-0.3%+13.9%
Q4 2022+16.2%+19.5%+14.0%
Q3 2022-23.1%-16.4%-26.5%
Q2 2022-6.4%+0.1%+3.5%
Q1 2022-23.7%-27.6%-12.2%
Q4 2021+2.4%+3.2%+3.2%
Q3 2021-7.8%-10.9%-13.6%
Q2 2021-15.1%-18.9%-18.3%
Q1 2021-7.0%-7.5%-17.2%
Q4 2020+4.0%+6.6%+8.3%
Q3 2020+3.2%+0.5%+10.7%
Q2 2020+13.6%+17.7%+31.7%
Q1 2020+9.0%+11.9%+16.3%
Q4 2019-11.9%-21.7%-28.9%
Q3 2019-4.4%-4.5%-0.6%
Q2 2019+6.8%+10.7%+11.3%
Q1 2019-3.9%-8.1%-1.5%
Q4 2018-4.6%-3.6%-9.4%
Q3 2018-3.0%+4.8%+10.5%
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q1 2016
Q1 2015
Q4 2014
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro